Viewing Study NCT02962960


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-01-06 @ 8:24 AM
Study NCT ID: NCT02962960
Status: COMPLETED
Last Update Posted: 2023-01-12
First Post: 2016-09-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations
Sponsor: AstraZeneca
Organization: